Bank Of Montreal Biotechnology

Bank Of Montreal

$201 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ENTA Enanta Pharmaceuticals Inc	$214M	$256,000 0.0% of portfolio	33,868	Q2 2025 Added 32.8%
ABCL Ab Cellera Biologics Inc.	$1.71B	$240,000 0.0% of portfolio	70,089	Q2 2025 Added 46.22%
BCRX Biocryst Pharmaceuticals Inc	$1.36B	$238,000 0.0% of portfolio	26,584	Q2 2025 Added 99.36%
XNCR Xencor Inc	$706M	$221,000 0.0% of portfolio	28,209	Q2 2025 Added 160.52%
VIR Vir Biotechnology, Inc.	$751M	$207,000 0.0% of portfolio	41,096	Q2 2025 Added 243.21%
RLAY Relay Therapeutics, Inc.	$628M	$190,000 0.0% of portfolio	55,174	Q2 2025 Added 73.62%
AVXL Anavex Life Sciences Corp.	$712M	$183,000 0.0% of portfolio	19,955	Q2 2025 Added 0.38%
RCKT Rocket Pharmaceuticals, Inc.	$243M	$180,000 0.0% of portfolio	73,800	Q2 2025 New
VERV Verve Therapeutics, Inc.	$667M	$173,000 0.0% of portfolio	15,456	Q2 2025 Reduced 49.02%
RPTX Repare Therapeutics Inc.	$77.2M	$145,000 0.0% of portfolio	104,919	Q2 2025 Reduced 0.3%
FOLD Amicus Therapeutics, Inc.	$2.31B	$143,000 0.0% of portfolio	25,058	Q2 2025 New
SAGE Sage Therapeutics, Inc.	$516M	$141,000 0.0% of portfolio	15,467	Q2 2025 Reduced 4.3%
LXRX Lexicon Pharmaceuticals, Inc.	$272M	$95,000 0.0% of portfolio	100,000	Q1 2025 Added 42.86%
RCUS Arcus Biosciences, Inc.	$965M	$92,000 0.0% of portfolio	11,304	Q2 2025 Added 3.72%
NVAX Novavax Inc	$747M	$90,000 0.0% of portfolio	14,431	Q2 2025 Added 1.14%
RXRX Recursion Pharmaceuticals, Inc.	$996M	$79,000 0.0% of portfolio	15,718	Q2 2025 Added 32.79%
ALEC Alector, Inc.	$261M	$73,000 0.0% of portfolio	52,380	Q2 2025 New
MRVI Maravai Lifesciences Holdings, Inc.	$391M	$72,000 0.0% of portfolio	30,069	Q2 2025 New
PRQR Pro Qr Therapeutics N.V.	$170M	$61,000 0.0% of portfolio	30,000	Q4 2023 New
DMAC Dia Medica Therapeutics Inc.	$186M	$60,000 0.0% of portfolio	15,560	Q4 2024 New
GERN Geron Corp	$521M	$47,000 0.0% of portfolio	34,008	Q2 2025 Added 3.18%
NKTX Nkarta, Inc.	$107M	$46,000 0.0% of portfolio	27,843	Q2 2025 Reduced 25.53%
AKBA Akebia Therapeutics, Inc.	$522M	$45,000 0.0% of portfolio	12,630	Q2 2025 Added 0.37%
VYGR Voyager Therapeutics, Inc.	$184M	$35,000 0.0% of portfolio	11,499	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$109M	$34,000 0.0% of portfolio	24,200	Q2 2025 Added 16.35%
IBRX Immunity Bio, Inc.	$1B	$33,000 0.0% of portfolio	12,522	Q2 2025 Reduced 11.97%
HRTX Heron Therapeutics, Inc.	$162M	$32,000 0.0% of portfolio	15,495	Q2 2025 Reduced 40.63%
ONCY Oncolytics Biotech Inc	$81M	$29,000 0.0% of portfolio	38,736	Q2 2025 Reduced 1.1%
IPA Immuno Precise Antibodies Ltd.	$41.5M	$23,000 0.0% of portfolio	22,050	Q2 2025 Reduced 0.03%
LEXX Lexaria Bioscience Corp.	$5.65M	$12,000 0.0% of portfolio	14,033	Q1 2025 Added 0.24%
VXRT Vaxart, Inc.	$46.8M	$6,000 0.0% of portfolio	15,125	Q1 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.